Axsome Therapeutics, Inc. · NASDAQ:AXSM
Axsome Therapeutics, Inc. shareholders
As of Jun 30, 2026, 493 institutions reported holding Axsome Therapeutics, Inc., 73.8% of its shares. Largest: Vanguard, BlackRock and Invesco. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Axsome Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 4.3M | 8.2% | −55,806 | Aug 13, 2026 |
| BlackRock | 3.1M | 5.9% | −809K | Aug 7, 2026 |
| Invesco | 1.67M | 3.2% | +374K | Aug 14, 2026 |
| Fidelity | 1.54M | 2.9% | −27,832 | Aug 13, 2026 |
| Geode Capital | 967K | 1.8% | −196K | Aug 12, 2026 |
| Franklin Templeton | 914K | 1.7% | +430K | Aug 13, 2026 |
| Assenagon Asset Management S.A. | 909K | 1.7% | +43,406 | Aug 21, 2026 |
| Morgan Stanley | 804K | 1.5% | +327K | Aug 13, 2026 |
| State Street | 786K | 1.5% | −201K | Aug 7, 2026 |
| Deep Track Capital, LP | 700K | 1.3% | −400K | Aug 14, 2026 |